MENU
GENE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Genetic Technologies (GENE) Ownership - Who owns Genetic Technologies?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
60-66 Hanover Street
Phone
+61 384127000
Employees
60
Web
https://www.gtglabs.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
10.53M
P/E Ratio
N/A
Total Cash
3.73M
Projected Growth
N/A
Total Debt
382.32K
Revenue
8.49M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
0.97
Total Debt/Equity
73.54
Revenue/Share
1.47 USD as % of share price
Fundamentals
GENE
Capitalization
10.5M
P/E Ratio
N/A
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
3.73M
Total Cash/Share
0.97
Total Debt
382K
Total Debt/Equity
73.54
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.47%
Revenue
8.49M
ROE
N/A
Book Value
4.81M
P/B Ratio
3.48
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
161M
Current Ratio
1.67
Current Revenue Per Employee
45013.31
Dividends Per Share - Security
N/A
EBITDA
-12.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.41
Revenue To Assets
-105.21
Shares Held By Institutions
59K
Shares Outstanding - Current
3.85M
Total Liabilities
3.66M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-68.125
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company which engages in the business of genetic testing services
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60-66 Hanover Street
Phone
+61 384127000
Employees
60
Web
https://www.gtglabs.com